Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: the effect of digoxin.
about
Arrhythmia-provoking factors and symptoms at the onset of paroxysmal atrial fibrillation: a study based on interviews with 100 patients seeking hospital assistanceDrug therapy for atrial fibrillationManagement of the older person with atrial fibrillation.Atrial Fibrillation: The New Epidemic of the Ageing WorldPharmacotherapy of atrial fibrillation.Atrial fibrillation pearls and perils of managementWhich patient should be referred to an electrophysiologist: supraventricular tachycardia.Therapeutic potential of c-Myc inhibition in the treatment of hypertrophic cardiomyopathy.Emergency management of atrial fibrillationAtrial fibrillation: classification, pathophysiology, mechanisms and drug treatmentDistribution of fast heart rate episodes during paroxysmal atrial fibrillationThe safety of digoxin as a pharmacological treatment of atrial fibrillation.Pharmacotherapy changes following pacemaker implantation in patients with bradycardia-tachycardia syndrome.Cardioversion of atrial fibrillation.The drug treatment of atrial fibrillation.Antiarrhythmic drugs in the management of atrial fibrillation.Withdrawal of maintenance digoxin from institutionalized elderly.Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry).Tedisamil: a new novel antiarrhythmic.Managing atrial fibrillation in active patients and athletes.
P2860
Q24801446-E1F892C3-6662-4FE7-AC9A-09C747DF0CF6Q28218580-DBB870B9-ECA2-4B62-A93F-73D27AB7E480Q33144789-10D590BE-1E0F-4F26-A0E6-87EF56320126Q33168630-139092F7-3482-4841-867E-1E5E879CCF8FQ34182375-B81D588B-7E33-4055-A37A-0A8641238E60Q34183370-D4915A65-B847-49D5-8CDE-E107E55BD461Q34532879-BE2B815F-EF73-4A0B-8562-E703D3F8D1A1Q35165627-1E50E30A-4043-42EC-A4A9-F55A0756D30AQ35168643-55A94183-0B8F-42E7-9723-4EEDC30E0882Q35177830-3C1C109F-4681-46AF-AC33-A4F5DFC90FDAQ35367653-F0661F1E-C437-4B56-ADCA-862733F27C3FQ36446911-DB59AE76-AA17-4AFC-B568-C2B3517FB062Q36632222-ACADEE63-30F1-4F2D-AC5B-9C8C0074EE99Q38640147-0F14F49E-4E74-49FB-993D-6B2F132E2DEEQ41840056-C5C6BF95-075C-4D96-8E10-49058345ECABQ41948308-8515369D-0750-4436-9A9C-998CC448615BQ43239779-0C0567F1-F9FC-45AF-B18B-22581A865BAAQ43630565-8DE8338B-59AC-4FBA-86B1-B72FB4C4D7E4Q44783845-4192FB16-2421-4673-9F0E-D80D39FAC263Q46259162-23D83DCC-A292-4F83-8D66-1B6004A73B5B
P2860
Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: the effect of digoxin.
description
1990 nî lūn-bûn
@nan
1990 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
name
Time of occurrence, duration, ...... lation: the effect of digoxin.
@ast
Time of occurrence, duration, ...... lation: the effect of digoxin.
@en
type
label
Time of occurrence, duration, ...... lation: the effect of digoxin.
@ast
Time of occurrence, duration, ...... lation: the effect of digoxin.
@en
prefLabel
Time of occurrence, duration, ...... lation: the effect of digoxin.
@ast
Time of occurrence, duration, ...... lation: the effect of digoxin.
@en
P2093
P2860
P356
P1476
Time of occurrence, duration, ...... lation: the effect of digoxin.
@en
P2093
Jennings K
Metcalfe MJ
P2860
P304
P356
10.1136/HRT.63.4.225
P577
1990-04-01T00:00:00Z